121 related articles for article (PubMed ID: 8864546)
1. Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects.
Lacroix JS; Ricchetti AP; Morel D; Mossimann B; Waeber B; Grouzmann E
Br J Pharmacol; 1996 Aug; 118(8):2079-84. PubMed ID: 8864546
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients.
Lacroix JS; Mosimann BL
J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539
[TBL] [Abstract][Full Text] [Related]
3. Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans.
Malis DD; Grouzmann E; Morel DR; Mutter M; Lacroix JS
Br J Pharmacol; 1999 Feb; 126(4):989-96. PubMed ID: 10193779
[TBL] [Abstract][Full Text] [Related]
4. Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose.
Cervin A; Onnerfält J; Edvinsson L; Grundemar L
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1724-8. PubMed ID: 10556147
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs.
Revington M; Lacroix JS; Potter EK
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):823-31. PubMed ID: 9457655
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y is a vasoconstrictor in human nasal mucosa.
Baraniuk JN; Silver PB; Kaliner MA; Barnes PJ
J Appl Physiol (1985); 1992 Nov; 73(5):1867-72. PubMed ID: 1282125
[TBL] [Abstract][Full Text] [Related]
7. Post-exercise nasal vasoconstriction and hyporeactivity: possible involvement of neuropeptide Y.
Lacroix JS; Correia F; Fathi M; Grouzmann E
Acta Otolaryngol; 1997 Jul; 117(4):609-13. PubMed ID: 9288221
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
[TBL] [Abstract][Full Text] [Related]
9. Effect of intranasal treatment with capsaicin on the recurrence of polyps after polypectomy and ethmoidectomy.
Zheng C; Wang Z; Lacroix JS
Acta Otolaryngol; 2000 Jan; 120(1):62-6. PubMed ID: 10779188
[TBL] [Abstract][Full Text] [Related]
10. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
Lacroix JS; Ulman LG; Potter EK
Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adults.
Taverner D; Bickford L; Shakib S; Tonkin A
Eur J Clin Pharmacol; 1999 Sep; 55(7):509-13. PubMed ID: 10501820
[TBL] [Abstract][Full Text] [Related]
12. The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial.
Bickford L; Shakib S; Taverner D
Br J Clin Pharmacol; 1999 Jul; 48(1):53-6. PubMed ID: 10383560
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP.
Lacroix JS; Stjärne P; Anggård A; Lundberg JM
Acta Physiol Scand; 1988 Jun; 133(2):183-97. PubMed ID: 3227914
[TBL] [Abstract][Full Text] [Related]
14. Changes in nasal airway resistance and secretory response in the guinea pig after nasal challenge with capsaicin and histamine.
Asakura K; Narita S; Kojima T; Saito H; Kataura A
Eur Arch Otorhinolaryngol; 1994; 251(4):224-8. PubMed ID: 7917256
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin-desensitization to the human nasal mucosa selectively reduces pain evoked by citric acid.
Geppetti P; Tramontana M; Del Bianco E; Fusco BM
Br J Clin Pharmacol; 1993 Feb; 35(2):178-83. PubMed ID: 8443036
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic and neuropeptide Y supersensitivity in denervated nasal mucosa vasculature of the pig.
Lacroix JS; Lundberg JM
Eur J Pharmacol; 1989 Oct; 169(1):125-36. PubMed ID: 2599007
[TBL] [Abstract][Full Text] [Related]
17. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
Browning S; Housley D; Richards R; Eccles R
Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
Lacroix JS
Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
[TBL] [Abstract][Full Text] [Related]
19. The effects of oral administration of (-)-menthol on nasal resistance to airflow and nasal sensation of airflow in subjects suffering from nasal congestion associated with the common cold.
Eccles R; Jawad MS; Morris S
J Pharm Pharmacol; 1990 Sep; 42(9):652-4. PubMed ID: 1981905
[TBL] [Abstract][Full Text] [Related]
20. The effect of topical phenylpropanolamine on nasal secretion and nasal airway resistance after histamine challenge in man.
Löth S; Bende M
Clin Otolaryngol Allied Sci; 1985 Feb; 10(1):15-9. PubMed ID: 4006263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
